-
novembre 4, 2019 Blood cancers: a “new generation” stem cell transplant significantly reduces complications for patients
In a Phase One-Two clinical trial, the great majority of patients with blood cancers are on the road to recovery, thanks to the UM171 molecule, discovered at the Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal.
![]()
-
octobre 28, 2019 Anne Marinier receives the Prix d’excellence 2019 des diplômés de l’UQAR
Anne Marinier, Principal Investigator and Director of Medicinal Chemistry at IRIC, has been awarded the Prix d’excellence des diplômés de l’Université du Québec à Rimouski (UQAR). This prestigious distinction was bestowed upon her on Saturday, October 26, 2019, at the official ceremony held at the Hôtel Rimouski – Centre des congrès…
![]()
-
septembre 20, 2019 Shedding light on new mechanisms related to cell migration
IRIC Investigators have made major discoveries involving the mechanisms regulating collective cell migration. Notably, this type of displacement is used by cancer cells that break away from a primary tumor to colonize another part of the body and form metastases…
![]()
-
septembre 13, 2019 Speeding up the drug discovery process to help patients: Michel Bouvier co-senior author of a study published in Nature Communications
An international research team has developed a new strategy that can predict the potential clinical implications of new therapeutic compounds based on simple cellular responses. This discovery was partly led by scientists affiliated with Université de Montréal (UdeM), and represents a major step forward in developing more effective drugs with fewer side effects, much faster than before. The researchers conducted their work at Centre de Recherche de l’Hôpital Ste-Justine and published their findings in the prestigious journal Nature Communications.
![]()
-
juillet 8, 2019 Treatment of leukemia: IRIC Investigators publish in Cancer Cell
Researchers at UdeM have discovered a molecular process implicated in the action of anti-leukemia drugs, opening new avenues for the development of effective treatments for this disease.
![]()
-
juin 27, 2019 Trang Hoang is awarded the Ordre national du Québec and the Ordre de Montréal
On June 20, 2019, Trang Hoang, Principal Investigator at IRIC, was appointed Officer of the Ordre national du Québec. The honorary decoration, awarded by Premier François Legault, is the greatest distinction handed out by the Government of Quebec, paying tribute to exceptional people who have done outstanding work for the province.
![]()
-
novembre 14, 2019 Planned donation from Michel Bouvier and Muriel Aubry
On this National Philanthropy Day, IRIC salutes the exceptional commitment made by its Chief Executive Officer, Dr. Michel Bouvier, and his partner, Dr. Muriel Aubry, by announcing their testamentary donation in support of the Université de Montréal and the Institute for Research in Immunology and Cancer (IRIC).
-
septembre 6, 2019 Mrs. Élaine and Mr. Réal Raymond once again show their commitment by donating $100,000 in support of Brian Wilhelm’s research
IRIC is proud to announce a $100,000 donation from Mrs. Élaine and Mr. Réal Raymond in support of Brian Wilhelm’s research in pediatric leukemia.
The couple renews its philanthropic commitment… -
septembre 6, 2019 IRIC on the road: 2019 student recruitment tour
The Academic Affairs team will once again take part this fall in the IRIC on the road student recruitment tour by participating in many graduate studies fairs held by various Canadian universities.
These recruitment activities provide students with a valuable opportunity to meet… -
juillet 8, 2019 $110,250 raised at the 10th Blais Family Fund Golf Tournament to benefit IRIC
On Friday, July 5, 2019, 225 people gathered at the Buckingham Golf Club for the 10th Blais Family Fund Golf Tournament. A record amount of $110,250 was raised to support cancer research efforts carried out at IRIC. Pierre Blais, he himself a leukemia survivor, thanks to an experimental treatment suggested by Dr. Guy Sauvageau, Principal Investigator at IRIC, is the driving force behind the event, which every year brings together family and friends devoted to the cause.
-
juillet 1, 2019 IRIC Student Recruitment Event 2019
The IRIC Student Recruitment Event offers students interested in pursuing graduate studies in the field of cancer research a unique opportunity to participate in an international student recruitment event at the Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal. The 2019 edition took place from June 12th to 14th, 2019.
-
juin 28, 2019 $150,000 in funding from the Richard and Edith Strauss Foundation for two promising cancer research projects
IRIC is proud to announce $150,000 in funding from the Richard and Edith Strauss Foundation for two promising cancer research projects. For the “Identification of biological targets influencing the response to anti-AML drugs” project, Dr. Guy Sauvageau received $100,000 in funding. As for Dr. Sonia Cellot, Paediatric hematologist at CHU Sainte-Justine, and Brian Wilhelm, they received $50,000 in financial support for their project titled “Characterising the stem/progenitor cell of origin of high fatality pediatric leukemia”.
-
juin 6, 2019 $10M awarded to IRIC for the development of new cancer-fighting drugs and immunotherapies
IRIC has been awarded a 10-million dollar grant from the government of Quebec’s Fonds d’accélération des collaborations en santé (FACS), to develop new cancer-fighting drugs in collaboration with biopharmaceutical company Bristol-Myers Squibb and collaborators from seven academic research centres from Quebec and abroad.